Home Your basket
• Auditory screening in neo...
   Price 8.50 €
• Comparison of stapes prot...
   Price 15.00 €
• Carcinogenesis of the eth...
   Price 10.50 €
• Schwannoma of the tongue:...
   Price 5.50 €
• Bilateral vestibular loss...
   Price 10.50 €
• Comparative study using A...
   Price 10.50 €
• Frontal sinus osteoma and...
   Price 5.50 €
• Interventional phoniatry...
   Price 14.00 €
• Prospective evaluation of...
   Price 10.50 €
• Usefulness and limitation...
   Price 10.50 €
• A case of nasal NK/T cell...
   Price 5.50 €
• The symphonix symposium u...
   Price 8.50 €
• Hearing preservation in p...
   Price 10.50 €
• Notes on voice and speech...
   Price 8.50 €
• Respiratory epithelial ad...
   Price 12.50 €
• Cowden syndrome: Otolaryn...
   Price 12.00 €
• Bilateral cleft lip and c...
   Price 14.00 €
• Laryngeal schwannoma: A c...
   Price 8.50 €
• Surgical treatement by in...
   Price 12.50 €
• Social consequence of a d...
   Price 10.50 €
• Vertigo and pathology of ...
   Price 10.50 €
• Congenital anomalies of n...
   Price 14.00 €
• A remnant tooth in an ede...
   Price 8.50 €
• Merkel cell carcinoma of ...
   Price 8.50 €
• Guidelines for the clinic...
   Price 12.50 €
• Synovial sarcoma of the h...
   Price 5.50 €
• Hearing loss and vestibul...
   Price 10.50 €
• Laryngeal schwannoma: A c...
   Price 5.50 €
• Chronic laryngitis...
   Price 8.50 €
• Rhinoplasty: Advantages a...
   Price 10.50 €
• Disability in patients wi...
   Price 10.50 €
• Transsexuality: Speech th...
   Price 10.50 €
• Reconstruction of bone de...
   Price 10.50 €
• The ultra-low resistance ...
   Price 5.50 €

Total Order 335.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 1 - 2010 o

PHONIATRICS

Voice related quality of life after botulinum toxin injection for spasmodic dysphonia


Authors : Gama A. C. C. 1<br />Menezes LN, Maia AA, Rezende Neto AL, Oliveira JB. (Belo Horizonte)

Ref. : Rev Laryngol Otol Rhinol. 2010;131,1:39-44.

Article published in english
Downloadable PDF document english



Summary : Introduction: Laryngeal Focal Dystonia (LFD) leads to a type of voice with a strained and tense quality which has a neurological origin, affecting the social-emotional realms of the individuals, and their quality of life. Aims: Measure the voice-related quality of life of patients with Adductor LFD pre and post-treatment with Botox®‚ injection followed by voice therapy, using the Voice-Related Quality of Life (V-RQOL). Study Design: Prospective study. Methods: Adductor 11 female patients aged between 33 and 74 years with a diagnosis of Adductor LFD were evaluated. All patients underwent a neurological evaluation. Laryngoscopy was performed with both rigid and flexible endoscopes. Speech and Language evaluation followed the Evaluation of Voice Protocol, proposed by Behlau, Pontes (1995). The American V-RQOL measure was utilized. Results: Statistical analysis demonstrated significant difference (p< 0,05). 81.8% of patients showed higher scores post-Botox®‚ for the social-emotional and physical domain. In the overall V-RQOL scores 72.7% of patients showed greater scores post-treatment. Conclusions: There was an improvement in the quality of life for these patients post-treatment. The V-RQOL proved to be an efficient tool to measure the treatment outcomes of LFD pre and post botulinum toxin injection.

Price : 10.50 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE